Atrasentan in Patients With IgA Nephropathy
Clinical trial NCT04573478 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04573478
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-11
- Primary completion
- 2028-04-14
- Enrollment
- 404
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.